Intelligent Bio Solutions completes usability study for FDA submission
Tweet Send to a Friend
Intelligent Bio Solutions Inc. (NASDAQ: INBS) announced the completion of a usability study for its Intelligent Fingerprinting Drug Screening System ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


